SH PHARMA Declares Interim Dividend of RMB 0.10 per Share for First-Half 2026

Bulletin Express08-27

Shanghai Pharmaceuticals Holding Co., Ltd. (SH PHARMA) has announced an interim ordinary dividend of RMB 1 for every 10 shares, equivalent to RMB 0.10 per share, for the six months ended 30 June 2026. The dividend, pertaining to the financial year ending 31 December 2026, was approved by shareholders on 25 June 2026 and disclosed on 28 August 2026.

Key distribution details—including the default payment currency, applicable exchange rate for Hong Kong-listed H shares, ex-dividend date, record date, and payment date—will be confirmed in a subsequent notice. Withholding-tax arrangements are also pending disclosure. Tricor Investor Services Limited will act as the Hong Kong share registrar for processing share transfers tied to dividend entitlement.

At the time of the announcement, SH PHARMA’s board comprises four executive directors (Yang Qiuhua, Shen Bo, Li Yongzhong, Dong Ming), one non-executive director (Zhang Wenxue), one employee representative director (Zhao Yong), and four independent non-executive directors (Wang Zhong, Man Kwan, Xue Yunkui, Wang Qian).

All other terms, including any implications for listed warrants or convertible securities, are marked as not applicable in the filing.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1126004338?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-27 19:44","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1126004338","market":"hk","top_or_hot":-1,"title":"SH PHARMA Declares Interim Dividend of RMB 0.10 per Share for First-Half 2026","media":"Bulletin Express","content":"<p>Shanghai Pharmaceuticals Holding Co., Ltd. (SH PHARMA) has announced an interim ordinary dividend of RMB 1 for every 10 shares, equivalent to RMB 0.10 per share, for the six months ended 30 June 2026. The dividend, pertaining to the financial year ending 31 December 2026, was approved by shareholders on 25 June 2026 and disclosed on 28 August 2026.</p>\n<p>Key distribution details—including the default payment currency, applicable exchange rate for Hong Kong-listed H shares, ex-dividend date, record date, and payment date—will be confirmed in a subsequent notice. Withholding-tax arrangements are also pending disclosure. Tricor Investor Services Limited will act as the Hong Kong share registrar for processing share transfers tied to dividend entitlement.</p>\n<p>At the time of the announcement, SH PHARMA’s board comprises four executive directors (Yang Qiuhua, Shen Bo, Li Yongzhong, Dong Ming), one non-executive director (Zhang Wenxue), one employee representative director (Zhao Yong), and four independent non-executive directors (Wang Zhong, Man Kwan, Xue Yunkui, Wang Qian).</p>\n<p>All other terms, including any implications for listed warrants or convertible securities, are marked as not applicable in the filing.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>SH PHARMA Declares Interim Dividend of RMB 0.10 per Share for First-Half 2026</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSH PHARMA Declares Interim Dividend of RMB 0.10 per Share for First-Half 2026\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-08-27 19:44</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shanghai Pharmaceuticals Holding Co., Ltd. (SH PHARMA) has announced an interim ordinary dividend of RMB 1 for every 10 shares, equivalent to RMB 0.10 per share, for the six months ended 30 June 2026. The dividend, pertaining to the financial year ending 31 December 2026, was approved by shareholders on 25 June 2026 and disclosed on 28 August 2026.</p>\n<p>Key distribution details—including the default payment currency, applicable exchange rate for Hong Kong-listed H shares, ex-dividend date, record date, and payment date—will be confirmed in a subsequent notice. Withholding-tax arrangements are also pending disclosure. Tricor Investor Services Limited will act as the Hong Kong share registrar for processing share transfers tied to dividend entitlement.</p>\n<p>At the time of the announcement, SH PHARMA’s board comprises four executive directors (Yang Qiuhua, Shen Bo, Li Yongzhong, Dong Ming), one non-executive director (Zhang Wenxue), one employee representative director (Zhao Yong), and four independent non-executive directors (Wang Zhong, Man Kwan, Xue Yunkui, Wang Qian).</p>\n<p>All other terms, including any implications for listed warrants or convertible securities, are marked as not applicable in the filing.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02607","symbol_name":"上海医药","start_time":0,"source_url":"","article_id":"1126004338","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1126004338","pubTimestamp":1787831090,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Shanghai Pharmaceuticals Holding Co., Ltd. (SH PHARMA) has announced an interim ordinary dividend of RMB 1 for every 10 shares, equivalent to RMB 0.10 per share, for the six months ended 30 June...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02607":"上海医药"},"translate_title":"上海医药宣派2026年上半年中期股息每股0.10元","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02607":1},"content_text":"Shanghai Pharmaceuticals Holding Co., Ltd. (SH PHARMA) has announced an interim ordinary dividend of RMB 1 for every 10 shares, equivalent to RMB 0.10 per share, for the six months ended 30 June 2026. The dividend, pertaining to the financial year ending 31 December 2026, was approved by shareholders on 25 June 2026 and disclosed on 28 August 2026.\nKey distribution details—including the default payment currency, applicable exchange rate for Hong Kong-listed H shares, ex-dividend date, record date, and payment date—will be confirmed in a subsequent notice. Withholding-tax arrangements are also pending disclosure. Tricor Investor Services Limited will act as the Hong Kong share registrar for processing share transfers tied to dividend entitlement.\nAt the time of the announcement, SH PHARMA’s board comprises four executive directors (Yang Qiuhua, Shen Bo, Li Yongzhong, Dong Ming), one non-executive director (Zhang Wenxue), one employee representative director (Zhao Yong), and four independent non-executive directors (Wang Zhong, Man Kwan, Xue Yunkui, Wang Qian).\nAll other terms, including any implications for listed warrants or convertible securities, are marked as not applicable in the filing.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.49.0","shortVersion":"4.49.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1126004338","isCrawlerRequest":true}